✦ LIBER ✦

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12 Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

✍ Scribed by Robert F. Storey; Steen Husted; Robert A. Harrington; Stanley Heptinstall; Robert G. Wilcox; Gary Peters; Mark Wickens; Håkan Emanuelsson; Paul Gurbel; Peer Grande; Christopher P. Cannon

Book ID: 119266975
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 797 KB
Volume: 50
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2007.07.058

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bleeding risk with AZD6140, a reversible

Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial

✍ S. Husted; R. A. Harrington; C. P. Cannon; R. F. Storey; P. Mitchell; H. Emanuel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Comparison of ticagrelor, the first reve

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

✍ Stefan James; Axel Åkerblom; Christopher P. Cannon; Håkan Emanuelsson; Steen Hus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Comparison of ticagrelor, the first reve

✍ Stefan James; Axel Åkerblom; Christopher P. Cannon; Håkan Emanuelsson; Steen Hus 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Safety, Tolerability, and Initial Effica

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Trial

✍ Christopher P. Cannon; Steen Husted; Robert A. Harrington; Benjamin M. Scirica; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Inhibitory Effects of Ticagrelor Compare

Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes: The PLATO (PLATelet inhibition and patient Outcomes) PLATELET Substudy

✍ Robert F. Storey; Dominick J. Angiolillo; Shankar B. Patil; Bhaloo Desai; Rosema 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Comparison of the effects of pretreatmen

Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes

✍ Emilia Solinas; Giuliana Gobbi; George Dangas; Roxana Mehran; Martin Fahy; Luigi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 233 KB